Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,324

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,859

Class I recallsReasonable probability of serious health consequences

24,440

Class II recallsTemporary or medically reversible health consequences

2,900

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,095 recalls

Newest recallhttps://www.fsis.usda.gov/recalls-alerts/kayem-foods-inc--recalls-meat-and-poultry-products-due-possible-temperature-abusePublished October 17, 2026

Most affected stateHawaii 200 recalls mention this state

State: OK ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 21, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,440
Class I	9,859
Class III	2,900
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,440
Class I	9,859
Class III	2,900
Not Yet Classified	2

FDA Recall TerminatedTerminated: September 24, 2024Historical recordClass II

PF-Neostigmine Methylsulfate Injection, USP 3 mg/3 mL (1 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500 12th Street Extension West Columbia, SC 29172, NDC 69374-932-33, UPC 3 69374-93233 2.

by Nephron Sterile Compounding Center LLC

Reason: CGMP Deviations: Potential for cross contamination due to product carry over.
Published: November 23, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 24, 2024Historical recordClass II

PF-Labetalol HCl Injection, USP 20 mg/4 mL (5 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500 12th Street Extension West Columbia, SC 29172, NDC 69374-946-34, UPC 3 69374 94634 6.

by Nephron Sterile Compounding Center LLC

Reason: CGMP Deviations: Potential for cross contamination due to product carry over.
Published: November 23, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 13, 2023Historical recordClass II

Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc. Morgantown, WV 36505, Made in India, NDC 0378-3634-05

by Viatris Inc

Reason: Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.
Published: November 23, 2022
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

0.9% Sodium Chloride Injection, USP, 100 mL flexible container bag, Rx Only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC 0990-7984-37

by ICU Medical Inc

Reason: Lack of assurance of sterility: Bags have the potential to leak in the flexible containers which may compromise sterility.
Published: November 23, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 18, 2023Historical recordClass II

Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par Pharmaceutical Chestnut Ridge, NY 10977 U.S.A. Mfg. by: Par Forumulations Private Limited,9/215, Pudupakkam, Kelambakkam - 603 103. NDC 49884-038-01

by Par Formulations Private Limited

Reason: Failed Impurities/Degradation Specifications
Published: November 23, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 23, 2023Historical recordClass II